CD44+CD166+ colon cancer cells display a higher ability to form tumors in immunodeficient mice as compared to CD44+CD166−, CD44−CD166− or CD44−CD166− cell populations [20], making this an useful combination for the identification of colon CSCs. Here, ALCAM is linked to malignant colon neoplasm.